Before becoming a member of Horizon, Dr. Thompson was a gaggle scientific director in pharmaceutical growth at AbbVie, where she was the medical lead for risankizumab , supporting world submissions and approvals. Before AbbVie, Dr. Thompson has had a career spanning medical improvement, business improvement and medical communications, and has additionally labored at Raptor, InterMune and Amgen. Dr. Jeffrey W. Sherman joined Horizon in June 2009 as government vice chairman, growth and regulatory affairs and chief medical officer and all through his time at Horizon has assumed varied responsibilities in addition to chief medical officer. Before joining Horizon, Cox was vice chairman, capital markets at BMO Capital Markets, the place he suggested clients on debt financing transactions across various levels of the capital construction.
Client Technology Overview
Currently he’s chief strategy officer of Information & Telecommunication Systems Group, basic manager of Strategy Planning & Development Office, Information & Telecommunication Systems Group. Dr. Jeff Himawan has served on the board of administrators since July 2007. Dr. Himawan has been a managing director of Essex Woodlands Health Ventures, a venture capital agency, since 2004.